Regeneron Currently Down Eight Consecutive Days, On Track for Longest Losing Streak Since May 2018 -- Data Talk
16 Novembro 2023 - 1:39PM
Dow Jones News
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $789.41,
down $2.97 or 0.37%
--Would be lowest close since Oct. 31, 2023, when it closed at
$779.89
--Currently down nine of the past 10 days
--Currently down eight consecutive days; down 5.17% over this
period
--Longest losing streak since May 9, 2018, when it fell for nine
straight trading days
--Worst eight day stretch since the eight days ending Oct. 30,
2023, when it fell 5.85%
--Up 1.22% month-to-date
--Up 9.41% year-to-date
--Down 6.51% from its all-time closing high of $844.37 on Aug.
21, 2023
--Up 6.81% from 52 weeks ago (Nov. 17, 2022), when it closed at
$739.08
--Down 6.51% from its 52-week closing high of $844.37 on Aug.
21, 2023
--Up 16.01% from its 52-week closing low of $680.49 on Jan. 9,
2023
--Traded as low as $785.83
--Down 0.83% at today's intraday low
--Fourth least active stock in the Nasdaq 100 today
All data as of 11:07:11 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 16, 2023 11:24 ET (16:24 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
